跳至主要内容
临床试验/NCT04581421
NCT04581421已完成不适用

The Role of Dietary Carbohydrate and Fat Availability in the Regulation of Hepatic Lipid Content

Hvidovre University Hospital1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2020年12月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
Liverfat

研究概览

简要总结

The purpose of this study is to investigate dietary compositions effect on liverfat measured by magnetic resonance imaging.

详细描述

Overweight but otherwise healthy men will be included in the study which is a randomized diet intervention study in a cross over design.

The study involves 2 intervention periods of 5 days each, during which the participant ingests two different types of experimental diet. Participants will in randomized order (determined by block randomization) ingest a diet with low carbohydrate and high fat content, and a diet with high carbohydrate and low fat content.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 50 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Healthy men being 18-50 years old.
  • Overweight (BMI 25-35)
  • Low to moderate physical activity level, defined as ≤ 1 weekly session of aerobic exercise.
  • Non-smokers
  • No use of medicine

排除标准

  • Fasting blood glucose indicating overt diabetes (≥7 mmol/l)
  • HbA1C >48 mmol/mol
  • Fasting plasma triacylglycerol indicating dyslipidemia (≥2.2 mmol/l)
  • FIB-4 score >1.45
  • Contraindications for MR-scan: abdominal height exceed limitations of the MR-scanner, pacemaker or other electronic device implanted, implanted metal devices, severe claustrophobia.

结局指标

主要结局

Liverfat

时间窗: (MRS Day -1 (before intervention starts), Day 5 (after diet intervention is completed)

The effect of high-carbohydrate/low-fat vs low-carbohydrate/high-fat diet on change in MRS determined liver fat.

次要结局

  • Glycogen((MRS Day -1 (before intervention starts), Day 5 (after diet intervention is completed))
  • fasting blood triacylglycerol concentration((Day 0 and Day 6 of the diet intervention))
  • Insulin clearance determined during steady state insulin infusion((Day 0 and Day 6 of the diet intervention))
  • fasting hepatic glucose output((Day 0 and Day 6 of the diet intervention))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kirstine Nyvold Bojsen-Moeller

Principal investigator, MD, PhD

Hvidovre University Hospital

研究点 (1)

Loading locations...

相似试验